【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
03.2.1 Product Profiles
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Disease Overview
06.1 Understanding the Disease
06.2 Etiology
06.2.1 Autoimmune Reaction
06.2.2 Genes
06.2.3 Environment
06.3 Stages of CD
06.4 Epidemiology
06.4.1 Global
06.4.2 US
06.4.3 UK
06.5 Symptoms
06.5.1 Diarrhea
06.5.2 Fever & Fatigue
06.5.3 Abdominal Pain & Cramping
06.5.4 Perianal Disease & Blood in the Stool
06.5.5 Reduced Appetite & Weight Loss
06.6 Diagnosis & Testing
06.6.1 Early Tests and Exams
06.6.2 Endoscopy and Biopsy
06.6.3 Chromoendoscopy
06.6.4 Small Intestinal Imaging
06.7 Treatment
06.7.1 Medication
06.7.2 Diet & Nutrition
06.7.3 Surgery
07.CD Pipeline Landscape
07.1 Some of the emerging therapeutic options for CD:
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 CD Market in the US
08.3.1 Market Size and Forecast
08.4 CD Market in Japan
08.4.1 Market Size and Forecast
09.Market Segmentation by Drug Class
09.1 Five Forces Analysis
10.Geographical Segmentation
11.Buying Criteria
12.Market Growth Drivers
13.Drivers and their Impact
14.Market Challenges
15.Impact of Drivers and Challenges
16.Market Trends
17.Trends and their Impact
18.Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 AbbVie
18.2.2 Astra Zeneca
18.2.3 Biogen Idec
18.2.4 Johnson and Johnson
18.2.5 Takeda Pharmaceutical
18.2.6 UCB
18.3 Other Prominent Vendors
19.Key Vendor Analysis
19.1 AbbVie Inc.
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Product Segmentation by Revenue 2013
19.1.4 Product Segmentation by Revenue 2012 and 2013
19.1.5 Sales by Geography
19.1.6 Business Strategy
19.1.7 Key Developments
19.1.8 SWOT Analysis
19.2 AstraZeneca plc
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation by Revenue 2013
19.2.4 Business Segmentation by Revenue 2011-2013
19.2.5 Sales by Geography
19.2.6 Business Strategy
19.2.7 Key Developments
19.2.8 SWOT Analysis
19.3 Biogen Idec
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue 2013
19.3.4 Geographical Segmentation by Revenue 2013
19.3.5 Business Strategy
19.3.6 Key Developments
19.3.7 SWOT Analysis
19.4 Johnson & Johnson
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation by Revenue 2013
19.4.4 Business Segmentation by Revenue 2012 and 2013
19.4.5 Geographical Segmentation by Revenue 2013
19.4.6 Business Strategy
19.4.7 Recent Developments
19.4.8 SWOT Analysis
19.5 Takeda Pharmaceuticals
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation by Revenue 2013
19.5.4 Business Segmentation by Revenue 2013
19.5.5 Geographical Segmentation by Revenue 2013
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
19.6 UCB
19.6.1 Key Facts
19.6.2 Business Overview
19.6.3 Product Segmentation by Revenue 2013
19.6.4 Product Segmentation by Revenue 2012 and 2013
19.6.5 Geographical Segmentation by Revenue 2013
19.6.6 Business Strategy
19.6.7 Recent Developments
19.6.8 SWOT Analysis
20.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Overview of CD
Exhibit 3: Types of CD
Exhibit 4: Expected Number of Global CD Cases 2015-2022
Exhibit 5: Global Variation in Incidence Rates for CD in 2012 (in percent)
Exhibit 6: Prevalence of CD in the US
Exhibit 7: Incidence Rate of CD in the US
Exhibit 8: Symptoms of CD
Exhibit 9: CD: Diagnosis & Testing
Exhibit 10: CD: Treatment
Exhibit 11: Treatment Landscape for CD
Exhibit 12: CD: Treatment Pathway
Exhibit 13: CD Clinical Trial by Phase
Exhibit 14: CD Clinical Trial by Status
Exhibit 15: Snapshot of Global CD Market 2014
Exhibit 16: Global CD Market 2014-2019 (US$ billion)
Exhibit 17: CD Market in the US 2014-2019 (US$ billion)
Exhibit 18: CD Market in Japan 2014-2019 (US$ billion)
Exhibit 19: Global CD Market Segmentation by Drug Class
Exhibit 20: Benefits and Risks of ASA’s
Exhibit 21: Global CD Market by Geographical Segmentation 2014
Exhibit 22: Approved Biologics for CD
Exhibit 23: AbbVie’s Humira Global Revenue 2010-2013 (US$ million)
Exhibit 24: AstraZeneca Sales by Therapy Area 2013
Exhibit 25: Biogen’s Tysabri Global Revenue 2011-2013 (US$ million)
Exhibit 26: Biogen’s Tysabri Quarter Sales of 2014 (US$ million)
Exhibit 27: Johnson & Johnson Sales by Therapeutic Area (Pharmaceuticals) 2013
Exhibit 28: Johnson & Johnson Remicade Global Revenue 2010-2013 (US$ million)
Exhibit 29: Johnson & Johnson Stelara Global Revenue 2010-2013 (US$ million)
Exhibit 30: UCB’s Cimzia Global Revenue 2010-2013 (US$ million)
Exhibit 31: AbbVie Inc.: Product Segmentation by Revenue 2013
Exhibit 32: AbbVie Inc.: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 33: AbbVie Inc.: Sales by Geography 2013
Exhibit 34: AstraZeneca plc: Business Segmentation by Revenue 2013
Exhibit 35: AstraZeneca plc: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 36: AstraZeneca plc: Sales by Geography 2013
Exhibit 37: Biogen Idec: Business Segmentation by Revenue 2013
Exhibit 38: Biogen Idec: Geographical Segmentation by Revenue 2013
Exhibit 39: Johnson & Johnson: Business Segmentation by Revenue 2013
Exhibit 40: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 41: Johnson & Johnson: Geographical Segmentation by Revenue 2013
Exhibit 42: Takeda Pharmaceuticals: Business Segmentation by Revenue 2013
Exhibit 43: Takeda Pharmaceuticals: Business Segmentation by Revenue 2013 (US$ million)
Exhibit 44: Takeda Pharmaceuticals: Geographical Segmentation by Revenue 2013
Exhibit 45: UCB: Product Segmentation by Revenue 2013
Exhibit 46: UCB: Product Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 47: UCB: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル：クローン病（CD）治療薬の世界市場2015-2019■ 英文：Global Crohn's Disease (CD) Market 2015-2019
■ 発行日：2015年3月11日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5419
■ 調査対象地域：グローバル
- プライベートブランド食品および飲料の米国市場2016-2020ABSTRACTAbout Private-Label Food and Beverage Products labeled as private are those that are owned by the retailers themselves rather than manufacturers. These products are also referred to as name brands, store brands, own label, retailer brands, or generics. Private-label products are available in nearly all food and beverage categories. Technavio’s analysts forecast the private-label food and b …
- クラウドゲームの世界市場2015-2019About Cloud Gaming In cloud gaming, the games reside in a vendor's server. These games can be accessed through a pre-installed client program from any internet-connected device. These cloud games utilize streaming technology and gamers can access a game from any geographical location. Vendors provide cloud games as web-based subscription services or on a pay-per-use subscription basis. Cloud games …
- アジアの殺生物剤市場In terms of volume, the Asia-Pacific biocides market is projected to grow at a CAGR of 3.7% from 2015 to 2020. Japan accounts for a larger share of 65.7% in the Asia-Pacific biocides market in 2014, and is expected to grow at a CAGR of 3.0% during the forecast period. This growth is primarily driven by increased focus on hygiene and growing concerns over the spread of infectious diseases in both r …
- スマートウィンドウ（Smart Windows)材料市場2014-2021※当レポートはスマートウィンドウの市場機会、ビジネスモデル分析、市場規模予測、主要企業の戦略などをまとめました。 In the past five years or so, smart (i.e. self-dimming) windows have taken off in both residential and commercial building markets. They are also increasingly used in automobiles and trucks. There are several different smart windows technologies, but all of them are materials plays in one way or another. NanoMarkets believes that, as a resul …
- バイオ技術投資レポート：プライベート・エクイティ及びベンチャーキャピタル投資動向PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding Summary GlobalData’s "PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding" report provides in-depth analysis of the current trends and factors shaping the private equity and venture capital segments of the financial industry …
- 世界の遺伝子検査市場（2012- 2016）TechNavio's analysts forecast the Global Genetic Testing market to grow at a CAGR of 9.45 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing global aging population. The Global Genetic Testing market has also been witnessing the increasing availability of Direct to Consumer (DTC) tests. However, the absence of credible standard procedures …
- ウェアラブル・ゲームの世界市場：企業、ゲームデバイス、ソリューションWearable gaming represents an emerging entrant into the digital entertainment market that is best defined from a mobile gaming perspective. Non-wearable mobile gaming is played on various wireless devices (smartphones, tablets, phablets, etc.), which have limited interface capabilities compared to desktop, laptop, or console gaming. In many ways, wearable technology causes even more limitations, b …
- 関節鏡の世界市場2017-2021About Arthroscopy DevicesAn arthroscopy is a minimally invasive surgical procedure used to visualize and diagnose problems in the joint through an arthroscope. Arthroscope has a small lens and the fiber optic light of the device is connected to a camera and monitor, which helps the surgeon to observe and perform surgery. This technique is carried out in the joints of knees, shoulders, hips, elbows …
- 世界の電子書籍（e-Book）市場（2014-2018）About E-books e-books are books available in a digital format, which allows readers to access content anywhere and anytime using their handheld devices. The Global e-Book market is the fastest growing segment in Global Book Publishing industry. It accounts for approximately 11.9 percent of total Book Publishing market in 2013. The segment contribution is expected to reach 26.3 percent by 2018. Tec …
- 世界主要国の子宮頸癌検査（パップテスト）/HPV検査（医療機器）市場The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technolog …
- 世界の臨床診断意思決定支援(CDSS)市場動向及び予測（～2018）Countries across the globe are struggling to combat issues such as escalating healthcare costs, poor or inconsistent quality of healthcare, rapid expansion in healthcare insurance, and changing healthcare reform mandates. These are further exacerbated by growing consumerism, globalization, changing demographics and lifestyles, and growing incidences of diseases that are expensive to treat. Resolvi …
- 熱障壁コーティング（TBC）の世界市場分析：製品別（金属、セラミック、金属間化合物）、技術別（EB-PVD、HVOF、CVD、エアプラズマ）、コーティングコンビネーション別（セラミックYSZ、Al 2 O 3、MCrAlY、ムライトベース）、用途別（固定発電所、航空宇宙、自動車）、セグメント予測The global thermal barrier coatings market is expected to reach a market size of USD 22.30 billion by 2024, according to a new report by Grand View Research, Inc. The industry is expected to witness significant growth over the forecast period owing to the increased adoption of air plasma and vapor deposition technologies for coating application, thereby increasing the demand from various applicati …
- Surge Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Surge Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Surge Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- 世界の物流ITシステム市場：トラッキング・モニタリング/情報総合/電子データ交換(EDI)/データベース管理システムなどThe efficient movement of freight is essential for any business, economy and also for the quality of life. In recent years, there has been a substantial demand for digital logistics system in the marketplace across verticals. The demand is surging due to the obvious benefits of costs, productivity and customer satisfaction of digital logistics. With potential opportunities in emerging verticals, c …
- リン酸塩の世界市場：リン酸アンモニウム、リン酸カルシウム、リン酸、リン酸カリウム、トリポリリン酸ナトリウムThe global phosphate market was USD 68.51 Billion in 2016, and is projected to reach USD 75.17 Billion by 2021, at a CAGR of 1.9% during the forecast period. Global focus on increasing agricultural output and increasing demand for phosphate from the foods & beverages industry is expected drive the market during the forecast period. The global phosphate market is classified on the basis of type/der …
